[{"evidenceId":7820,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"CTNNB1 (β-catenin), a transcriptional activator, is recurrently mutated in various cancers including endometrial and hepatocellular cancers.","id":null,"lastEdit":"2017-03-09","status":null,"gene":{"entrezGeneId":1499,"hugoSymbol":"CTNNB1","name":"catenin beta 1","oncogene":true,"curatedIsoform":"ENST00000349496","curatedRefSeq":"NM_001904.3","geneAliases":["MRD19","CTNNB","armadillo"],"tsg":false},"articles":[]},{"evidenceId":7821,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"The CTNNB1 gene encodes the protein β-catenin, a transcriptional activator involved in the WNT signaling pathway (PMID: 22682243, 22617422). In the absence of WNT ligands, β-catenin is sequestered in the cytosol by its interaction with the APC/AXIN destruction complex. This destruction complex includes GSK3β, a kinase responsible for phosphorylating key β-catenin residues and targeting β-catenin for degradation. Engagement of WNT receptors by WNT ligands results in disruption of the APC/AXIN destruction complex, freeing β-catenin to transit into the nucleus and mediate target gene activation by interaction with transcription factors of the TCF/LEF family. Important transcriptional targets of β-catenin/TCF include Cyclin D1 and MYC (PMID: 10201372, 9727977). β-catenin also influences cell-cell adhesion and cell migration (PMID: 15001769). Mutations of CTNNB1 result in aberrant accumulation of the β-catenin protein and are prevalent in a wide range of solid tumors, including uterine/endometrial carcinoma (primarily endometrioid subtype) (PMID: 9721853, 23636398), ovarian (primarily endometrioid and clear cell) (PMID: 19349352, 20942669), hepatocellular carcinoma (PMID: 9635572, 11443619, 22561517, 22634756, 23788652), colorectal carcinoma (PMID: 9065402, 9515795, 22810696), gastric adenocarcinoma (PMID: 25079317), lung adenocarcinoma (PMID: 25079552, 22980975, 18948947), bladder carcinoma (PMID: 24476821), desmoid tumors (PMID: 10597266, 10367940), and medulloblastoma (PMID: 22832583, 22820256, 22722829). Cancers with CTNNB1 mutations are presumed to be resistant to pharmacologic inhibition of upstream components of the WNT pathway, including WNT ligands, WNT receptors and tankyrase, instead requiring direct inhibition of β-catenin function (PMID: 19351922, 22682243).","id":null,"lastEdit":"2017-03-09","status":null,"gene":{"entrezGeneId":1499,"hugoSymbol":"CTNNB1","name":"catenin beta 1","oncogene":true,"curatedIsoform":"ENST00000349496","curatedRefSeq":"NM_001904.3","geneAliases":["MRD19","CTNNB","armadillo"],"tsg":false},"articles":[{"pmid":"22682243","title":"Wnt/β-catenin signaling and disease.","journal":"Cell","pubDate":"2012 Jun 8","volume":"149","issue":"6","pages":"1192-205","authors":"Clevers H et al","elocationId":"doi: 10.1016/j.cell.2012.05.012","link":null,"reference":"Clevers H et al. Cell. 2012 Jun 8;149(6)1192-205.","abstract":null},{"pmid":"22561517","title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.","journal":"Nature genetics","pubDate":"2012 May 6","volume":"44","issue":"6","pages":"694-8","authors":"Guichard C et al","elocationId":"doi: 10.1038/ng.2256","link":null,"reference":"Guichard C et al. Nature genetics. 2012 May 6;44(6)694-8.","abstract":null},{"pmid":"22722829","title":"Novel mutations target distinct subgroups of medulloblastoma.","journal":"Nature","pubDate":"2012 Aug 2","volume":"488","issue":"7409","pages":"43-8","authors":"Robinson G et al","elocationId":"doi: 10.1038/nature11213","link":null,"reference":"Robinson G et al. Nature. 2012 Aug 2;488(7409)43-8.","abstract":null},{"pmid":"10201372","title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.","journal":"Nature","pubDate":"1999 Apr 1","volume":"398","issue":"6726","pages":"422-6","authors":"Tetsu O et al","elocationId":"","link":null,"reference":"Tetsu O et al. Nature. 1999 Apr 1;398(6726)422-6.","abstract":null},{"pmid":"24476821","title":"Comprehensive molecular characterization of urothelial bladder carcinoma.","journal":"Nature","pubDate":"2014 Mar 20","volume":"507","issue":"7492","pages":"315-22","authors":"Cancer Genome Atlas Research Network.","elocationId":"doi: 10.1038/nature12965","link":null,"reference":"Cancer Genome Atlas Research Network.. Nature. 2014 Mar 20;507(7492)315-22.","abstract":null},{"pmid":"10597266","title":"Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).","journal":"Oncogene","pubDate":"1999 Nov 11","volume":"18","issue":"47","pages":"6615-20","authors":"Tejpar S et al","elocationId":"","link":null,"reference":"Tejpar S et al. Oncogene. 1999 Nov 11;18(47)6615-20.","abstract":null},{"pmid":"19351922","title":"Drugging the Wnt pathway: problems and progress.","journal":"Journal of the National Cancer Institute","pubDate":"2009 Apr 15","volume":"101","issue":"8","pages":"548-50","authors":"Garber K","elocationId":"doi: 10.1093/jnci/djp084","link":null,"reference":"Garber K. Journal of the National Cancer Institute. 2009 Apr 15;101(8)548-50.","abstract":null},{"pmid":"9065402","title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.","journal":"Science (New York, N.Y.)","pubDate":"1997 Mar 21","volume":"275","issue":"5307","pages":"1787-90","authors":"Morin PJ et al","elocationId":"","link":null,"reference":"Morin PJ et al. Science (New York, N.Y.). 1997 Mar 21;275(5307)1787-90.","abstract":null},{"pmid":"22634756","title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.","journal":"Nature genetics","pubDate":"2012 May 27","volume":"44","issue":"7","pages":"760-4","authors":"Fujimoto A et al","elocationId":"doi: 10.1038/ng.2291","link":null,"reference":"Fujimoto A et al. Nature genetics. 2012 May 27;44(7)760-4.","abstract":null},{"pmid":"22832583","title":"Dissecting the genomic complexity underlying medulloblastoma.","journal":"Nature","pubDate":"2012 Aug 2","volume":"488","issue":"7409","pages":"100-5","authors":"Jones DT et al","elocationId":"doi: 10.1038/nature11284","link":null,"reference":"Jones DT et al. Nature. 2012 Aug 2;488(7409)100-5.","abstract":null},{"pmid":"19349352","title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.","journal":"The American journal of pathology","pubDate":"2009 May","volume":"174","issue":"5","pages":"1597-601","authors":"Kuo KT et al","elocationId":"doi: 10.2353/ajpath.2009.081000","link":null,"reference":"Kuo KT et al. The American journal of pathology. 2009 May;174(5)1597-601.","abstract":null},{"pmid":"23788652","title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.","journal":"Genome research","pubDate":"2013 Sep","volume":"23","issue":"9","pages":"1422-33","authors":"Kan Z et al","elocationId":"doi: 10.1101/gr.154492.113","link":null,"reference":"Kan Z et al. Genome research. 2013 Sep;23(9)1422-33.","abstract":null},{"pmid":"25079317","title":"Comprehensive molecular characterization of gastric adenocarcinoma.","journal":"Nature","pubDate":"2014 Sep 11","volume":"513","issue":"7517","pages":"202-9","authors":"Cancer Genome Atlas Research Network.","elocationId":"doi: 10.1038/nature13480","link":null,"reference":"Cancer Genome Atlas Research Network.. Nature. 2014 Sep 11;513(7517)202-9.","abstract":null},{"pmid":"9727977","title":"Identification of c-MYC as a target of the APC pathway.","journal":"Science (New York, N.Y.)","pubDate":"1998 Sep 4","volume":"281","issue":"5382","pages":"1509-12","authors":"He TC et al","elocationId":"","link":null,"reference":"He TC et al. Science (New York, N.Y.). 1998 Sep 4;281(5382)1509-12.","abstract":null},{"pmid":"9635572","title":"Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.","journal":"Cancer research","pubDate":"1998 Jun 15","volume":"58","issue":"12","pages":"2524-7","authors":"Miyoshi Y et al","elocationId":"","link":null,"reference":"Miyoshi Y et al. Cancer research. 1998 Jun 15;58(12)2524-7.","abstract":null},{"pmid":"9515795","title":"Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.","journal":"Cancer research","pubDate":"1998 Mar 15","volume":"58","issue":"6","pages":"1130-4","authors":"Sparks AB et al","elocationId":"","link":null,"reference":"Sparks AB et al. Cancer research. 1998 Mar 15;58(6)1130-4.","abstract":null},{"pmid":"25079552","title":"Comprehensive molecular profiling of lung adenocarcinoma.","journal":"Nature","pubDate":"2014 Jul 31","volume":"511","issue":"7511","pages":"543-50","authors":"Cancer Genome Atlas Research Network.","elocationId":"doi: 10.1038/nature13385","link":null,"reference":"Cancer Genome Atlas Research Network.. Nature. 2014 Jul 31;511(7511)543-50.","abstract":null},{"pmid":"22980975","title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.","journal":"Cell","pubDate":"2012 Sep 14","volume":"150","issue":"6","pages":"1107-20","authors":"Imielinski M et al","elocationId":"doi: 10.1016/j.cell.2012.08.029","link":null,"reference":"Imielinski M et al. Cell. 2012 Sep 14;150(6)1107-20.","abstract":null},{"pmid":"9721853","title":"Beta-catenin mutation in carcinoma of the uterine endometrium.","journal":"Cancer research","pubDate":"1998 Aug 15","volume":"58","issue":"16","pages":"3526-8","authors":"Fukuchi T et al","elocationId":"","link":null,"reference":"Fukuchi T et al. Cancer research. 1998 Aug 15;58(16)3526-8.","abstract":null},{"pmid":"11443619","title":"beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.","journal":"Cancer","pubDate":"2001 Jul 1","volume":"92","issue":"1","pages":"136-45","authors":"Wong CM et al","elocationId":"","link":null,"reference":"Wong CM et al. Cancer. 2001 Jul 1;92(1)136-45.","abstract":null},{"pmid":"22810696","title":"Comprehensive molecular characterization of human colon and rectal cancer.","journal":"Nature","pubDate":"2012 Jul 18","volume":"487","issue":"7407","pages":"330-7","authors":"Cancer Genome Atlas Network.","elocationId":"doi: 10.1038/nature11252","link":null,"reference":"Cancer Genome Atlas Network.. Nature. 2012 Jul 18;487(7407)330-7.","abstract":null},{"pmid":"15001769","title":"Convergence of Wnt, beta-catenin, and cadherin pathways.","journal":"Science (New York, N.Y.)","pubDate":"2004 Mar 5","volume":"303","issue":"5663","pages":"1483-7","authors":"Nelson WJ et al","elocationId":"","link":null,"reference":"Nelson WJ et al. Science (New York, N.Y.). 2004 Mar 5;303(5663)1483-7.","abstract":null},{"pmid":"22617422","title":"The many faces and functions of β-catenin.","journal":"The EMBO journal","pubDate":"2012 Jun 13","volume":"31","issue":"12","pages":"2714-36","authors":"Valenta T et al","elocationId":"doi: 10.1038/emboj.2012.150","link":null,"reference":"Valenta T et al. The EMBO journal. 2012 Jun 13;31(12)2714-36.","abstract":null},{"pmid":"23636398","title":"Integrated genomic characterization of endometrial carcinoma.","journal":"Nature","pubDate":"2013 May 2","volume":"497","issue":"7447","pages":"67-73","authors":"Cancer Genome Atlas Research Network. et al","elocationId":"doi: 10.1038/nature12113","link":null,"reference":"Cancer Genome Atlas Research Network. et al. Nature. 2013 May 2;497(7447)67-73.","abstract":null},{"pmid":"18948947","title":"Somatic mutations affect key pathways in lung adenocarcinoma.","journal":"Nature","pubDate":"2008 Oct 23","volume":"455","issue":"7216","pages":"1069-75","authors":"Ding L et al","elocationId":"doi: 10.1038/nature07423","link":null,"reference":"Ding L et al. Nature. 2008 Oct 23;455(7216)1069-75.","abstract":null},{"pmid":"22820256","title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.","journal":"Nature","pubDate":"2012 Aug 2","volume":"488","issue":"7409","pages":"106-10","authors":"Pugh TJ et al","elocationId":"doi: 10.1038/nature11329","link":null,"reference":"Pugh TJ et al. Nature. 2012 Aug 2;488(7409)106-10.","abstract":null},{"pmid":"20942669","title":"ARID1A mutations in endometriosis-associated ovarian carcinomas.","journal":"The New England journal of medicine","pubDate":"2010 Oct 14","volume":"363","issue":"16","pages":"1532-43","authors":"Wiegand KC et al","elocationId":"doi: 10.1056/NEJMoa1008433","link":null,"reference":"Wiegand KC et al. The New England journal of medicine. 2010 Oct 14;363(16)1532-43.","abstract":null},{"pmid":"10367940","title":"Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.","journal":"Oncology research","pubDate":"1998","volume":"10","issue":"11-12","pages":"591-4","authors":"Miyoshi Y et al","elocationId":"","link":null,"reference":"Miyoshi Y et al. Oncology research. 1998;10(11-12)591-4.","abstract":null}]}]